Last $4.92 USD
Change Today +0.03 / 0.61%
Volume 1.0M
PGNX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. Israel M.D.

Executive Vice President of Medical Affairs, Progenics Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

57$838,596
As of Fiscal Year 2013

Background*

Dr. Robert J. Israel, M.D. serves as a Senior Vice President of Medical Affairs and Clinical Research at Progenics Pharmaceuticals, Inc. and served as its Senior Vice President, Medical Affairs since 2002. Dr. Israel has been a Consultant to the Solid Tumor Service at Sloan-Kettering since 1987. He joined Progenics Pharmaceuticals Inc. in October 1994 and served as its Vice President, Medical Affairs. Dr. Israel served as the Director, Clinical Research-Oncology and ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-789-2800
Fax: 914-789-2817

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
The University of Pennsylvania
BA
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Salary$418,158
Bonus$8,367
Total Annual Compensation$426,525

Stock Options*

All Other Compensation$15,728
Exercised Options5,000
Exercised Options Value$5,000
Exercisable Options167,832
Unexercisable Options116,668
Unexercisable Options Value$18,000
Total Value of Options$23,000
Total Number of Options289,500

Total Compensation*

Total Annual Cash Compensation$618,150
Total Short Term Compensation$426,525
Other Long Term Compensation$15,728
Total Calculated Compensation$838,596
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $4.92 USD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
$436.8K
James M. Gower Chairman, Chief Executive Officer and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$695.1K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.